Additionally, ROC analysis demonstrated that SYT4 was an effective prognostic marker for the 1- year survival rate (AUC value 0.837), and a suboptimal marker for the 3- and 5- year survival rate in GC patients (AUC value 0.622 and 0.649) (Fig. 1H). Here, SYT4 is linked to gastric cancer.